Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 657932, 8 pages
http://dx.doi.org/10.1155/2015/657932
Research Article

Granulocyte-Colony Stimulating Factor Increases Cerebral Blood Flow via a NO Surge Mediated by Akt/eNOS Pathway to Reduce Ischemic Injury

1Department of Medical Research, Buddhist Tzu Chi General Hospital, No. 707, Section 3, Zhongyang Road, Hualien City 970, Taiwan
2Institute of Pharmacology and Toxicology, Tzu Chi University, No. 701, Section 3, Zhongyang Road, Hualien City 970, Taiwan
3Graduate Institute of Medical Sciences, Taipei Medical University, No. 250, Wu-Hsing Street, Taipei 110, Taiwan
4Institute of Medical Sciences, Tzu Chi University, No. 701, Section 3, Zhongyang Road, Hualien City 970, Taiwan

Received 20 June 2014; Revised 6 November 2014; Accepted 7 November 2014

Academic Editor: Robert M. Starke

Copyright © 2015 Hock-Kean Liew et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Fisher and W. Schaebitz, “An overview of acute stroke therapy. Past, present, and future,” Archives of Internal Medicine, vol. 160, no. 21, pp. 3196–3206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Schneider, C. Krüger, T. Steigleder et al., “The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis,” The Journal of Clinical Investigation, vol. 115, no. 8, pp. 2083–2098, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L.-R. Zhao, Y. Navalitloha, S. Singhal et al., “Hematopoietic growth factors pass through the blood-brain barrier in intact rats,” Experimental Neurology, vol. 204, no. 2, pp. 569–573, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-T. Lee, K. Chu, K.-H. Jung et al., “Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia,” Brain Research, vol. 1058, no. 1-2, pp. 120–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. W.-R. Schäbitz, R. Kollmar, M. Schwaninger et al., “Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia,” Stroke, vol. 34, no. 3, pp. 745–751, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. W.-C. Shyu, S.-Z. Lin, H.-I. Yang et al., “Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells,” Circulation, vol. 110, no. 13, pp. 1847–1854, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. B.-G. Xiao, C.-Z. Lu, and H. Link, “Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection: cellular Medicine,” Journal of Cellular and Molecular Medicine, vol. 11, no. 6, pp. 1272–1290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. K. Jellema, V. L. Lima Passos, D. R. M. G. Ophelders et al., “Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia-ischemia,” Experimental Neurology, vol. 250, pp. 293–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. N. H. Khatibi, V. Jadhav, M. Saidi et al., “Granulocyte colony-stimulating factor treatment provides neuroprotection in surgically induced brain injured mice,” Acta Neurochirurgica, Supplementum, no. 111, pp. 265–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Gross and M. S. Wolin, “Nitric oxide: pathophysiological mechanisms,” Annual Review of Physiology, vol. 57, pp. 737–769, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. M. Zeiher, “Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation,” Nature, vol. 399, no. 6736, pp. 601–605, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Fulton, J. P. Gratton, T. J. McCabe et al., “Regulation of endothelium-derived nitric oxide production by the protein kinase Akt,” Nature, vol. 399, no. 6736, pp. 597–601, 1999. View at Google Scholar
  13. K. Ueda, H. Takano, H. Hasegawa et al., “Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 6, pp. e108–e113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. I. M. Macrae, M. J. Robinson, D. I. Graham, J. L. Reid, and J. McCulloch, “Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences,” Journal of Cerebral Blood Flow & Metabolism, vol. 13, no. 2, pp. 276–284, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Sharkey and S. P. Butcher, “Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery,” Journal of Neuroscience Methods, vol. 60, no. 1-2, pp. 125–131, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Sharkey, I. M. Ritchie, and P. A. T. Kelly, “Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat,” Journal of Cerebral Blood Flow and Metabolism, vol. 13, no. 5, pp. 865–871, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ioroi, M. Yonetani, and H. Nakamura, “Effects of hypoxia and reoxygenation on nitric oxide production and cerebral blood flow in developing rat striatum,” Pediatric Research, vol. 43, no. 6, pp. 733–737, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Tsukahara, D. V. Gordienko, and M. S. Goligorsky, “Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells,” Biochemical and Biophysical Research Communications, vol. 193, no. 2, pp. 722–729, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Chen, Y. Li, L. Wang et al., “Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats,” Stroke, vol. 32, no. 4, pp. 1005–1011, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Huang, P. L. Huang, J. Ma et al., “Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine,” Journal of Cerebral Blood Flow and Metabolism, vol. 16, no. 5, pp. 981–987, 1996. View at Google Scholar · View at Scopus
  21. S. Moncada and A. Higgs, “The L-arginine-nitric oxide pathway,” The New England Journal of Medicine, vol. 329, no. 27, pp. 2002–2012, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. N. E. Stagliano, W. D. Dietrich, R. Prado, E. J. Green, and R. Busto, “The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat,” Brain Research, vol. 759, no. 1, pp. 32–40, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Iadecola, F. Zhang, S. Xu, R. Casey, and M. E. Ross, “Inducible nitric oxide synthase gene expression in brain following cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 15, no. 3, pp. 378–384, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. V. L. Dawson and T. M. Dawson, “Nitric oxide neurotoxicity,” Journal of Chemical Neuroanatomy, vol. 10, no. 3-4, pp. 179–190, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. V. L. Dawson, T. M. Dawson, D. A. Bartley, G. R. Uhl, and S. H. Snyder, “Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures,” The Journal of Neuroscience, vol. 13, no. 6, pp. 2651–2661, 1993. View at Google Scholar · View at Scopus
  26. V. L. Dawson, T. M. Dawson, E. D. London, D. S. Bredt, and S. H. Snyder, “Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 14, pp. 6368–6371, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Willmot, L. Gray, C. Gibson, S. Murphy, and P. M. W. Bath, “A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow,” Nitric Oxide, vol. 12, no. 3, pp. 141–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Kuppusamy, S. T. Ohnishi, Y. Numagami, T. Ohnishi, and J. L. Zweier, “Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia,” Journal of Cerebral Blood Flow and Metabolism, vol. 15, no. 6, pp. 899–903, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-P. Olesen, A. Møller, P. I. Mordvintcev, R. Busse, and A. Mülsch, “Regional measurements of NO formed in vivo during brain ischemia,” Acta Neurologica Scandinavica, vol. 95, no. 4, pp. 219–224, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Shibata, N. Araki, J. Hamada, T. Sasaki, K. Shimazu, and Y. Fukuuchi, “Brain nitrite production during global ischemia and reperfusion: an in vivo microdialysis study,” Brain Research, vol. 734, no. 1-2, pp. 86–90, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Osuka, Y. Watanabe, N. Usuda, A. Nakazawa, M. Tokuda, and J. Yoshida, “Modification of endothelial NO synthase through protein phosphorylation after forebrain cerebral ischemia/reperfusion,” Stroke, vol. 35, no. 11, pp. 2582–2586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. E. B. Ringelstein, V. Thijs, B. Norrving et al., “AXIS 2 Investigators: granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial,” Stroke, vol. 44, no. 10, pp. 2681–2687, 2013. View at Publisher · View at Google Scholar